Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : What CVS's acquisition of Aetna could mean

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/28/2017 | 01:03pm CET

SAN FRANCISCO – A possible $66 billion takeover of health insurer Aetna by CVS Health could lower costs to both companies, leading to the hope that at least some savings might be passed through to patients – or it could be a sign that for a long-standing player in the medicine game, "the jig is up."

On Thursday, the Wall Street Journal, citing unnamed people who said they are familiar with the situation, reported CVS Healthcare was in talks to acquire Aetna for more than $200 per share. Representatives of both companies declined to comment on the report.

While at first glance, a bid by CVS, with its 9,000 national pharmacies, for Aetna might seem like the mouse swallowing the cat, it's actually the opposite. The market capitalization of CVS is currently about three times that of Aetna, approximately $180 billion versus $60 billion.

There are other facets to its business that make an insurance company an interesting target for a pharmacy, experts say.

Pharmacy benefit management

An important part of CVS' business is CVS Caremark, the pharmacy benefit management subsidiary of CVS Health. Pharmacy benefit management companies work with insurers to decide which drugs are most beneficial and cost-efficient. They also negotiate discounts from drug manufacturers.

"Aetna participants are likely to see the most benefit ... because CVS would be maybe able to offer them lower co-pays if they shop with them," said Joseph Agnese, a senior analyst with investment research firm CFRA.

Agnese says don't expect the deep discounts, but he adds that "the more (CVS) is purchasing, the better the deals they'll be able to get (from drug companies)."

CVS Caremark has the expertise and access to customers' pharmaceutical information and medical needs, so it makes sense that the company would want to expand that to include not just pharmacy, but full health care, says Mohamed Jalloh, a spokesman for the American Pharmacists Association.

"It could be that they're trying to expand their service and extend the pharmacy insurance benefit to insuring everything," said Jalloh.

Not everyone is convinced prices could come down for customers.

In a time of rising health care costs and bitter partisan fights over insurance and accessibility, the potential merger may mean more savings for the companies than individual users.

The merger is in many ways an indication for the pharmacy benefit management (PBM) industry "that the jig is up," said Adams Dudley, a professor of medicine and health policy at the University of California, San Francisco.

"The idea of a PBM was that they would negotiate really well and really hard with the drug companies and that the insurers didn't have the knowledge or the bandwidth to do that," said Dudley, who directs the UCSF Center for Healthcare Value.

"But it's become apparent that they're not saving people money because they keep all the profits themselves. People are suddenly realizing that if PBMs make a lot of profit, it just jacks up drug prices. It's completely the opposite of what we thought they would do," Dudley said.

The merger wouldn't likely save much money for consumers, in the opinion of Aaron Katz, an expert on health policy at the University of Washington's school of public health.

That doesn't necessarily mean it wouldn't save money for the companies. "Larger entities tend to be tougher negotiators over price and contracts," said Katz.

While the proponents of health company mergers often cite the cost savings of merged systems and the benefit to consumers, "I haven't seen much convincing evidence myself," said Katz.

Frustration over the unrealized savings that PBMs were supposed to bring could be a reason for CVS Healthcare to look into widening its reach to a broader swath of health care, should the lucrative PBM business go away.

"They skim an awful lot off the top. Their administrative profits are very high and that might not be sustainable in the future," Dudley said. As an example, he noted the low prices big box stores such as Costco are able to offer because they purchase directly from the manufacturers, saving the cut the PBMs were taking.

CVS is already on its way to expanding its offerings. The company currently runs more than 1,000 MinuteClinics staffed by nurse practitioners and physician assistants who can provide basic health care for walk-in patients.

For Aetna, mergers are a road it's been down. Two years ago it agreed to buy Louisville, Ky-based insurer Humana for $34 billion. However, the deal was abandoned earlier this year due to regulatory concerns.

Follow USA TODAY reporters Marco della Cava and Elizabeth Weise on Twitter.

© © 2017 Journal Media Group, source Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
11/16 CVS HEALTH : Makes Overdose-Reversal Drug Available Without Individual Prescript..
11/16 CVS HEALTH : Earns Perfect Score in 2018 Corporate Equality Index
11/16 CVS HEALTH : Surescripts Transforms Prescription Decision Process Between Physic..
11/15 CVS HEALTH : delivering next-day service come the new year
11/15 Bayer hires new blood to stem 'Amazon effect' in consumer health
11/15 CVS HEALTH : Delaware, CVS Health make overdose reversal drug available without ..
11/14 CVS HEALTH : Commits to Hiring 5,000 New Apprentices by 2022, Expands States Par..
11/13 CVS HEALTH : Ensuring Our Veterans Have Access to Care
11/11 CVS HEALTH : will offer overdose reversal drug naloxone without prescription
11/10 CVS HEALTH : Public Health and CVS Health Make Overdose-Reversal Drug Available ..
More news
News from SeekingAlpha
11/18 RGA Q3 2017 Letter - Amazon's Share Of E-Commerce = PayPal's Opportunity
11/17 40 Dividend Stocks Battling Into 2018
11/17 DIVIDEND CONTENDERS : 24 Increases Expected In The Next 11 Weeks
11/16 Who Is Afraid Of Big Bad Amazon?
11/16 CVS : Undervalued
Financials ($)
Sales 2017 184 B
EBIT 2017 9 954 M
Net income 2017 5 242 M
Debt 2017 24 377 M
Yield 2017 2,76%
P/E ratio 2017 14,08
P/E ratio 2018 12,18
EV / Sales 2017 0,52x
EV / Sales 2018 0,50x
Capitalization 71 598 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 84,5 $
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-10.43%71 598
WALGREENS BOOTS ALLIANCE-13.91%71 930
EXPRESS SCRIPTS HOLDING CO-9.96%35 081
MCKESSON CORPORATION1.20%29 630
CARDINAL HEALTH INC-20.09%18 128
AMERISOURCEBERGEN CORP.0.83%17 275